[HTML][HTML] Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong, L Zhu… - Frigid Zone …, 2024 - degruyter.com
Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …

Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong, L Zhu, Z Zhang… - degruyter.com
Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized
by a progressive decline in liver function, leading to disruptions in liver integrity and …

[HTML][HTML] Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong… - Frigid Zone …, 2024 - frigidzonemedicine.com.cn
Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …

[HTML][HTML] Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong… - Frigid Zone …, 2024 - frigidzonemedicine.com.cn
Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …

[HTML][HTML] Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong… - Frigid Zone …, 2024 - frigidzonemedicine.com.cn
Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …

[HTML][HTML] Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation

Q Zhang, W Zhao, Z Sun, X Dong… - Frigid Zone …, 2024 - frigidzonemedicine.com.cn
Background Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by
a progressive decline in liver function, leading to disruptions in liver integrity and metabolic …